Angioplasty with stent graft versus bare stent for recurrent cephalic arch stenosis in autogenous arteriovenous access for hemodialysis: A prospective randomized clinical trial

Shemesh, David; Goldin, Ilya; Zaghal, Ibrahim; Berlowitz, Daniel; Raveh, David; Olsha, Oded

doi:10.1016/j.jvs.2008.07.071

Cited by 141 publications

(110 citation statements)

References 25 publications

Supporting

Mentioning

108

Contrasting

Unclassified

Order By: Relevance

“…Due to the necessity for repeat treatment of relapses, avoidance of central venous dialysis catheters as a prophylaxis for central venous obstructions continues to be recommended [21]. In patients with central recurrent stenoses of the cephalic vein, superiority of covered stent grafts compared to normal bare stents in relation to the patency rate was able to be shown [90]. However, these results are a subject of controversy since the placement of a covered stent could induce central stenoses and occlusions that would prevent future placement of an ipsilateral vascular access [91].…”

Section: Central Venous Stenoses and Occlusionsmentioning

confidence: 99%

Diagnosis and Treatment of Insufficient Dialysis Vascular Access

Kamper

Faizy²,

Haage³

2015

Fortschr Röntgenstr

View full text Add to dashboard Cite

A wide variety of diagnostic and minimally invasive modalities is currently available to radiologists for providing sufficient medical care for dialysis patients. In addition to clinical examination, ultrasound is the first line imaging method in suspected dialysis vascular access dysfunction. The percutaneous approach is the primarily recommended therapeutic option in many cases. This article reviews the current diagnostic and therapeutic methods in dialysis vascular access insufficiency. Key Points: ??Vascular access dysfunction is often elicited by stenosed vessels, which are regularly associated with concomitant thrombosis. ??Stenoses are commonly observed in the anastomosis, vascular access vein and also in the central venous system. ??Beside the clinical examination, sonography is the diagnostic method of first choice. ??Percutaneous balloon dilatation frequently is the first treatment option. Citation Format: ??Kamper L, Faizy TD, Haage P. Diagnosis and Treatment of Insufficient Dialysis Vascular Access. Fortschr R?ntgenstr 2015; 187: 360???371

show abstract

Section: Central Venous Stenoses and Occlusionsmentioning

confidence: 99%

Diagnosis and Treatment of Insufficient Dialysis Vascular Access

Kamper

Faizy²,

Haage³

2015

Fortschr Röntgenstr

View full text Add to dashboard Cite

show abstract

“…In addition diabetes and hyperglycemia has been shown to have significant impact upon both endothelial dysfunction and proinflammatory pathways of atheroma [19]. Despite this, a lower than predicted incidence of diabetes in those with cephalic arch stenosis has been a consistent finding in multiple other studies [5,20,15]. Hammes et al have proposed that patients with diabetes have a wider cephalic arch than those without, thus reduced haemodynamic stress in this area [21].…”

Section: Discussionmentioning

confidence: 99%

“…One study of 11 patients demonstrated 6 month primary patency to be 82% with a Viabahn stent [3]. Another study retrospectively compared stent grafting with bare metal stents [15], finding primary patency to be 32% at 12 months with Viabahn stents compared to 0% with bare metal stents. Stent grafting should be considered with recurrent cephalic arch stenosis.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Venous Outflow Stenosis of the Brachiocephalic Fistula: A Single Entity, or is the Cephalic Arch Different?

Jackson¹,

Aitken²,

Kasthuri³

et al. 2014

J Vasc Med Surg

View full text Add to dashboard Cite

“…Gore, Flagstaff, AZ), external surface (Fluency; Bard Peripheral, Phoenix, AZ), or both internal and external surfaces of the stent (Flair; Bard Peripheral). These devices specifically target stenosis at the vein-graft anastomosis (VGA) and cephalic arch regions (1)(2)(3). In addition, investigators are using these devices in the management of arteriovenous access-associated pseudoaneurysms (4 -7).…”

mentioning

confidence: 99%

Stent Graft for Nephrologists

Salman

Asif

2010

Clinical Journal of the American Society of Nephrology

View full text Add to dashboard Cite

The role of the stent graft is emerging in the management of arteriovenous dialysis access. Physicians are incorporating this device in the management of three distinct problems-vein-graft anastomotic stenosis, pseudoaneurysm formation, and cephalic arch stenosis-with varying degrees of success. Indeed, a recent randomized, controlled trial to evaluate the role of angioplasty plus stent graft versus angioplasty alone for the management of stenosis at the vein-graft anastomosis led to the approval of the stent graft by the Food and Drug Administration; however, several elements of the management of stenosis at the vein-graft anastomosis/cephalic arch as well as the repair of pseudoaneurysms by stent graft remain controversial. The situation is further complicated and warrants a cost-to-benefit ratio analysis when the added cost of the device is appended to the procedure. In contrast to the controversies, angioplasty-induced complete vascular rupture is one situation in which a stent graft is indicated beyond any doubt. With recent conditional Food and Drug Administration approval, it is anticipated that the use of stent grafts might increase in our patients. In this context, it is critically important that nephrologists be familiar with the current controversies and consensus that surround the use of stent grafts for dialysis access. Just as therapeutic interventions are analyzed in other disciplines within nephrology, these experts must appraise the use of this device for dialysis access. This report presents an up-to-date synopsis on the use of the stent graft that would assist renal physicians in requesting or rejecting the device for the optimal management of their patient's vascular access dysfunction.

show abstract

Angioplasty with stent graft versus bare stent for recurrent cephalic arch stenosis in autogenous arteriovenous access for hemodialysis: A prospective randomized clinical trial

Cited by 141 publications

References 25 publications

Diagnosis and Treatment of Insufficient Dialysis Vascular Access

Diagnosis and Treatment of Insufficient Dialysis Vascular Access

Venous Outflow Stenosis of the Brachiocephalic Fistula: A Single Entity, or is the Cephalic Arch Different?

Stent Graft for Nephrologists

Contact Info

Product

Resources

About